Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Has reproduction · 67
Heterogeneity and Differentiation Trajectories of Infiltrating CD8+ T Cells in Lung Adenocarcinoma.
PMID 36358600 · PMC9658355 · Cancers · 2022 · 7 claims · 8 setups
Infiltrating CD8+ T cells in LUAD can be divided into ten transcriptionally distinct subsets: eight cytotoxic (CTL) subsets, one naive-like (NTL) subset, and one exhausted (ETL) subset.
-
Full-text index only
Multi-Omics reveals SPP1 + malignant and CXCR4(+) TAM crosstalk predicts immunotherapy response in lung adenocarcinoma.
PMID 42045760 · PMC13187092 · Discover oncology · 2026 · 8 claims · 8 setups
SPP1+ malignant and CXCR4+ TAM crosstalk drives CD8 T cell exhaustion and induces poor immunotherapy response
-
Full-text index only
An integrated single-cell lung cancer atlas reveals distinct fibroblast phenotypes between adenocarcinoma and squamous cell carcinomas.
PMID 41577803 · PMC12920623 · NPJ precision oncology · 2026 · 8 claims · 8 setups
Inflammatory CAFs (iCAFs) predominate in LUAD, whereas myofibroblastic CAFs (mCAFs) predominate in LUSC
-
Full-text index only
Advancing Prognosis Prediction and Immunotherapy Efficacy in Lung Adenocarcinoma Through Machine Learning: Novel Insights From Anoikis Regulator Patterns in Single-Cell Multiomics.
PMID 41488744 · PMC12764181 · International journal of genomics · 2026 · 8 claims · 8 setups
Epithelial and endothelial cells show the highest anoikis-enriched scores among LUAD TME cell types, with AT2-like Epi being the most anoikis-related epithelial subpopulation.
-
Has reproduction · 68
Multi-scale integrative analyses identify THBS2(+) cancer-associated fibroblasts as a key orchestrator promoting aggressiveness in early-stage lung adenocarcinoma.
PMID 35547750 · PMC9065207 · Theranostics · 2022 · 8 claims · 8 setups
THBS2 is a tumor size-independent biomarker that robustly predicts post-surgical OS and RFS in multiple independent early-stage LUAD cohorts
-
Full-text index only
Multiomic and functional validation of ACSL3, a regulator of fatty acid metabolism, as a lymph node metastasis-associated gene in lung adenocarcinoma.
PMID 41998631 · PMC13261843 · Respiratory research · 2026 · 8 claims · 8 setups
A five-gene FAM-related risk signature (ACSL3, MCAT, NDUFAB1, OLAH, ACSL4)-derived FScore stratifies LUAD prognosis across multiple independent cohorts
-
Full-text index only
Nested co-expression network analysis identifies compact gene clusters in a black box.
PMID 41934621 · PMC13163169 · Bioinformatics (Oxford, England) · 2026 · 8 claims · 6 setups
Nested-WGCNA is a two-stage algorithm that identifies coarse-grained modules (CGMs) and then, via core decomposition and renormalization, derives fine-grained modules (FGMs) representing subprocesses within each CGM
-
Full-text index only
Identification and validation of prognostic genes associated with M2 macrophage and heme metabolism in lung adenocarcinoma through bulk and single-cell RNA sequencing analysis.
PMID 41787185 · PMC13076703 · Discover oncology · 2026 · 8 claims · 8 setups
EPB41, ACP5, PPOX, RBM38, and TRIM58 were identified as prognostic genes for LUAD
-
Full-text index only
Dissecting origin factors of lymph node metastasis in non-small cell lung cancer via multimodal omics.
PMID 41975179 · PMC13250061 · Nature communications · 2026 · 8 claims · 8 setups
Epithelial cells in mLNs and matched mLN+ primary tumors (mLN+PTs) show enhanced cancer stemness (higher CytoTRACE scores) compared to mLN-negative and normal samples.
-
Full-text index only
Single-cell spatial analysis stratifies lung adenocarcinoma with rare actionable mutations and reveals immune-modulatory cellular crosstalk.
PMID 42013848 · PMC13198233 · Cell reports. Medicine · 2026 · 8 claims · 8 setups
Consensus meta-program (MP) expression patterns stratify LUAD patients with rare and reference oncogenic mutations into ICI-MP-H and ICI-MP-L subgroups reflecting differential predicted ICI benefit